Over the past 12 months, Tvardi Therapeutics insiders made no open-market purchases or sales of the stock.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Shaheen Wirk | Director | 0 | 146,397 | 146,397 | 52.9% | 02 May, 2025 |
| 2 | Wallace L Jr Hall | Director | 0 | 82,251 | 82,251 | 29.7% | 02 May, 2025 |
| 3 | Martin Vogelbaum | Director | 11,416 | 0 | 11,416 | 4.1% | 06 Jun, 2024 |
| 4 | Susan Ph.D. Shiff | Director | 5,613 | 0 | 5,613 | 2.0% | 06 Jun, 2024 |
| 5 | Jeffrey L. Ives | Director | 5,513 | 0 | 5,513 | 2.0% | 06 Jun, 2024 |
| 6 | Moltke Lisa Von | Director | 5,083 | 0 | 5,083 | 1.8% | 06 Jun, 2024 |
| 7 | Frederique Ph.D. Menzaghi | Chief Scientific Off,Svp Rd | 4,646 | 0 | 4,646 | 1.7% | 05 Feb, 2024 |
| 8 | Christopher Posner | President And Ceo | 4,370 | 0 | 4,370 | 1.6% | 04 Mar, 2025 |
| 9 | Helen M Boudreau | Director | 4,184 | 0 | 4,184 | 1.5% | 06 Jun, 2024 |
| 10 | Scott Terrillion | Sec'Y; Chief Compliance G.C. | 2,397 | 0 | 2,397 | 0.9% | 04 Mar, 2025 |
| 11 | Harrison M Jr Bains | Director | 1,595 | 0 | 1,595 | 0.6% | 05 Jun, 2023 |
| 12 | Joana Goncalves | Chief Medical Officer | 1,482 | 0 | 1,482 | 0.5% | 09 Apr, 2024 |
| 13 | Thomas Charles Reilly | Chief Financial Officer | 1,050 | 0 | 1,050 | 0.4% | 04 Mar, 2022 |
| 14 | Richard Makara | Vp, Head Of Accting;Controller | 377 | 0 | 377 | 0.1% | 16 Jun, 2022 |
| 15 | Ryan D Maynard | Chief Financial Officer | 223 | 0 | 223 | 0.1% | 12 Feb, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 09 Jun, 2026 | Michael S Wyzga | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 09 Jun, 2026 | Cynthia Smith | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 09 Jun, 2026 | Sujal Shah | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 09 Jun, 2026 | Susan Ph.D. Shiff | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 09 Jun, 2026 | Wallace L Jr Hall | Director | Acquired A | 6,000 | $0.00 | $0 | 6,000 | Direct |
| 29 Jan, 2026 | Imran Nizamudin Alibhai | Chief Executive Officer | Acquired A | 115,000 | $0.00 | $0 | 115,000 | Direct |
| 29 Jan, 2026 | Stephen Paul O'Brien | Principal Accounting Officer | Acquired A | 15,000 | $0.00 | $0 | 15,000 | Direct |
| 29 Jan, 2026 | John Saewook M.D. Kauh | Chief Medical Officer | Acquired A | 45,000 | $0.00 | $0 | 45,000 | Direct |
| 29 Jan, 2026 | Avi Daniel Conn | Chief Financial Officer | Acquired A | 45,000 | $0.00 | $0 | 45,000 | Direct |
| 16 Dec, 2025 | John Saewook M.D. Kauh | Chief Medical Officer | Acquired A | 17,500 | $0.00 | $0 | 17,500 | Direct |
| 16 Dec, 2025 | Avi Daniel Conn | Chief Financial Officer | Acquired A | 17,500 | $0.00 | $0 | 17,500 | Direct |
| 16 Dec, 2025 | Stephen Paul O'Brien | Principal Accounting Officer | Acquired A | 4,000 | $0.00 | $0 | 4,000 | Direct |
| 16 Dec, 2025 | Imran Nizamudin Alibhai | Chief Executive Officer | Acquired A | 47,500 | $0.00 | $0 | 47,500 | Direct |
| 07 Jul, 2025 | Samuel David Tweardy | TenPercentOwner | Disposed J | 315,658 | $0.00 | $0 | 0 | Indirect |
| 07 Jul, 2025 | Samuel David Tweardy | TenPercentOwner | Disposed J | 315,658 | $0.00 | $0 | 0 | Indirect |
| 15 Apr, 2025 | Wallace L Jr Hall | Director | Acquired A | 44,712 | — | — | 14,904 | Indirect |
| 15 Apr, 2025 | Shaheen Wirk | Director | Acquired A | 176,030 | — | — | 58,676 | Indirect |
| 15 Apr, 2025 | Wallace L Jr Hall | Director | Acquired A | 202,044 | — | — | 67,347 | Indirect |
| 15 Apr, 2025 | Shaheen Wirk | Director | Acquired A | 263,164 | — | — | 87,720 | Indirect |
| 17 Apr, 2025 | Shaheen Wirk | Director | Acquired A | 12,000 | $0.00 | $0 | 12,000 | Direct |